Impact on life expectancy of withdrawing thiopurines in patients with crohn’s disease in sustained clinical remission: a lifetime risk-benefit analysis

HIGHLIGHTS

• who: Julien Kirchgesner et al. from the Antimicrobials, Modelization, Evolution (IAME), Paris, France Editor:, University Hospital Llandough have published the research: Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn’s Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0157191]. June 6, 2016 of /1371/
• what: The authors developed a model-based risk-benefit analysis of withdrawing thiopurines in CD patients in prolonged remission.
• how: The authors developed a Markov model assessing risks and benefits of withdrawing thiopurines compared . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.